Hypersensitivity to Insulin Degludec: Case Analysis and Management Perspectives
Keywords:
IgE-mediated, LADA, insulin injection reactions
Abstract
From the introduction of human recombinant insulin preparations, insulin allergy has become rare, with a reported prevalence of approximately 2.4% (1). Most insulin injection reactions are immediate and IgE-mediated and can be classified as either Type I or Type IV hypersensitivity (1).
Downloads
How to Cite
References
Babak Aberumand, Samira Jeimy (2021) The complexities of insulin allergy: a case and approach. 17(1), 79.
Lucie Heinzerling, Adriano Mari, Karl‐christian Bergmann, Megon Bresciani, Guido Burbach, Ulf Darsow, Stephen Durham, Wytske Fokkens, Mark Gjomarkaj, Tari Haahtela, Ana Bom, Stefan Wöhrl, Howard Maibach, Richard Lockey (2013) The skin prick test - European standards. 3(1), 3.
L Heinzerling, K Raile, H Rochlitz, T Zuberbier, M Worm (2008) Insulin allergy: clinical manifestations and management strategies. 63(2), 148-155.
C Grieco, D Swain, S Colberg, E Dowling, K Baskette, L Zarrabi (2013) Effect of intensity of aerobic training on insulin sensitivity/resistance in recreationally active adults. 27(8), 2270-2276.
Published
2025-03-21
Issue
Section
License
Copyright (c) 2025 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.